Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > W Mark Hahn > Profile

W Mark Hahn

Affiliations

  • Chief Financial Officer at Verona Pharma Plc (VRNA), 2024-11-01
  • Director at Alsp Orchid Acquisition Corp I (ALOR), 2021-11-18
  • Chief Financial Officer at Dova Pharmaceuticals Inc. (DOVA), 2019-11-12
  • Evp And Cfo at Cempra Inc. (CEMP), 2017-02-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Dova Pharmaceuticals Inc.
 DOVA $6.28 2,500 Officer 2,500 2018-12-19 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Verona Pharma Plc
 VRNA $4.38 3,200 Officer 13,669,360 2024-10-25 Filing
Verona Pharma Plc
 VRNA $4.38 141,360 Officer 13,672,560 2024-10-24 Filing
Verona Pharma Plc
 VRNA $4.38 159,344 Officer 13,813,920 2024-10-22 Filing
Verona Pharma Plc
 VRNA $4.38 116,696 Officer 13,973,264 2024-10-21 Filing
Verona Pharma Plc
 VRNA $4.38 249,728 Officer 14,089,960 2024-10-18 Filing